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The side chains of residues Thr299and Thr301 in the Streptomyces particular class of compounds. By contrast, the loss of the
R61 DD-peptidase have been modified by site-directed muta- hydroxy group of the residue in position 299 yielded a seriously
genesis. These amino acids are part of a f-strand which forms a impaired enzyme. The rates of inactivation by penicillins were
wall of the active-site cavity. Thr299 corresponds to the second decreased 30-50-fold, whereas the reactions with cephalosporins
residue of the Lys-Thr(Ser)-Gly triad, highly conserved in were even more affected. The efficiency of hydrolysis against the
active-site ,-lactamases and penicillin-binding proteins (PBPs). peptide substrate was also seriously decreased. More surprisingly,
Modification of Thr30' resulted only in minor alterations of the the mutant was completely unable to catalyse transpeptidation
catalytic and penicillin-binding properties of the enzyme. No reactions. The conservation of an hydroxylated residue in this
selective decrease of the rate of acylation was observed for any position in PBPs is thus easily explained by these results.
INTRODUCTION
The membrane-bound penicillin-binding proteins (PBPs) control
the biosynthesis of the bacterial-cell-wall peptidoglycan (Frere et
al., 1992). In vitro, some of these proteins exhibit DD-carboxy-
peptidase and/or DD-transpeptidase activities. Together with the
active-site-serine fi-lactamases, they form a superfamily of
penicillin-recognizing enzymes which share the following proper-
ties: (1) the three-step kinetic model shown below (Model 1)
describes the interaction between the two types of enzymes and
fi-lactams (Frere and Joris, 1985; Christensen et al., 1990;
Waley, 1992); (2) some esters or thiolesters behave as substrates
for both types of enzymes (Govardhan and Pratt, 1987; Adam et
al., 1990; Jamin et al., 1991) according to the same Model 1; (3)
their three-dimensional structures exhibit striking similarities
(Kelly et al., 1986; Samraoui et al., 1986; Oefner et al., 1990); (4)
sequence alignments have allowed the identification of several
conserved elements (Joris et al., 1988, 1991) which probably play
important roles in the protein architecture or in the catalytic
mechanism.
One of the conserved elements is the well-known Lys-Thr(Ser)-
Gly sequence [KT(S)G], which is part of a f-sheet strand forming
one ofthe active-site walls. In the Streptomyces R61 DD-peptidase
(EC 3.4.16.4) this element is His298-Thr299-Gly300-Thr301 and
corresponds to Lys234-Thr235-Gly236-Ala237 in the class A f-
lactamases (Joris et al., 1988, 1991). Different studies have
demonstrated the importance of this element in the class A f-
lactamase catalysis: site-directed mutagenesis of the Bacillus
licheniformis fi-lactamase emphasized the role of Lys234 (Ellerby
et al., 1990; Brannigan et al., 1991); molecular modelling of f-
lactam antibiotics in the enzyme cavity of several class A enzymes
(Lamotte-Brasseur et al., 1991, 1992; Moews et al., 1990;
Strynadka et al., 1992) has shown that Thr235 might be involved
in substrate binding via a hydrogen bond formed between the
hydroxy group of the threonine and the carboxylate group of the
fi-lactam.
The residues which immediately follow the KT(S)G triad are
not conserved among the penicillin-recognizing enzymes and do
not play an essential role in the catalytic phenomena. However,
they appear to significantly affect the substrate profile of class A
fi-lactamases. In 1976, Hall and Knowles, by applying a selective
pressure on the TEM fi-lactamase after chemical mutagenesis,
observed a significant increase of the cephalosporinase/
penicillinase ratio. The mutation was later identified as alanine-
237-+threonine (Ala237Thr), and modifications of the same
residue (Healey et al., 1989) resulted in alterations of the
specificity profile of the enzyme. In the R61 DD-peptidase, the
first residue of the corresponding HTG triad, His298, has been
replaced by Lys and Gln, and both mutations resulted in proteins
seriously impaired in both their catalytic and penicillin-binding
properties (Hadonou et al., 1992).
In the present study, the importance of the ubiquitous hydroxyl
group of the second residue of the triad was assessed by replacing
Thr299 by Val. In turn, Thr30 , which corresponds to Ala327 in the
class A f,-lactamases, was replaced by Ser and Ile in the hope of
modifying the sensitivity of the DD-peptidase to penicillins or
cephalosporins and of obtaining a better understanding of the
secondary interactions which govern the relative efficiencies of
these two families of f,-lactams as inactivators of the DD-
peptidases.
Kinetic models
Two kinetic models have been used to describe the different
activities of the R61 DD-peptidase.
Model 1: carboxypeptidase activity and interaction with f,-lactam
inhibitors
E kCN E-C -+ > E<-* -3 oE+P(s)k (Model 1)
where E, C, E * C, E<C* and P(s) are respectively the enzyme, the
substrate of the fi-lactam inactivator, the non-covalent Henri-
Michaelis complex, and acylenzyme and the reaction products;
k 1, k+2 and k+3 are first-order rate constants and where K' =
(k1 + k+2)/k+,-
Abbreviation used: PBP(s), penicillin-binding protein(s).
* To whom correspondence should be sent.
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Model 2: transpeptidase activity (Jamin et al., 1993)
Pi
k+I k + kE +S ES -2 E-S*- E+H
Al k+E-S*.A S E+T (Model 2)
k+68 k k
E-S*S-A E+H
where E, S, A, E S, E-S*, P1, H and T are respectively the
enzyme, the donor substrate, the acceptor substrate, the Henri-
Michaelis complex, the acylenzyme, the leaving group, the
hydrolysis and transfer products and where K' = (k-1 + k+2)/k+1,
a = (k-4 + k+5)/k+4 and , = (k6 + k+7)/k+6.
MATERIALS AND METHODS
Chemicals were of the same origin as in the previous papers
(Wilkin et al., 1993a,b) and Table 1 summarizes the structures of
the various substrates.
Oligonucleotides were a gift of SmithKline Beecham,
Brockham Park, Surrey, U.K. The oligonucleotides utilized to
introduce the mutations were purified as described by Maniatis








where, at the level of the mutations, the lower nucleotides are
those of the wild-type gene.
Recombinant DNA procedures were as described by Wilkin et
al. (1993a). The construction of plasmids pDML42 (Thr301Ile),
pDML43 (Thr301Ser) and pDML39 (Thr299Val) by site-directed
mutagenesis was as described by Hadonou et al. (1991).
The production of the mutant DD-peptidases was done as
previously. Two different culture media were used: the YEME
medium (Wilkin et al., 1993a) and the TSB medium (Wilkin et
Table 1 Structures of the substrates
A and K are D-alanine and L-lysine respectively; Ac is acetyl.
R-NH-CH-CO-X-CH-OO-1
R' R"




































al., 1993b). The Thr301Ile and Thr301Ser mutants were produced
in the first medium and the Thr299Val mutant in the second.
Purification, determinations of kinetic parameters, de-
naturation and h.p.l.c. experiments were done exactly as
described by Varetto et al. (1987) and Wilkin et al. (1993a).
All experiments were performed at 37° C in 10 mM sodium
phosphate buffer, pH 7.0, unless otherwise stated.
Curve fitting was realized with the help of two software
packages. The ENZFITTER package allows data analysis by
non-linear regression (Leatherbarrow, 1987). The SIMFIT
software package which was kindly given by Dr. H. Holzhutter
(Institute of Biochemistry, Humbolt University, Berlin,
Germany), allows simulations and data analysis using models
based upon algebraic and/or differential equations (Holzhutter
and Colosimo, 1990). The equations used for fitting were those
described by Jamin et al. (1993). An additional simplification
could be made, since the substrate concentration could be
considered as much smaller than K', so that eqn. (5) of Jamin
et al. (1993) became:
VI f' (k+21K') [SI 1
Eo f+g'(k+21K) IS] 9'
where:
f= k+3ct3+ k+5,[A] + k+7[A] [S]
g'= a8+,/[A]+ [A] [S]
Fitting was used to calculate the kinetics parameters in the
transpeptidation pathway and was performed on three sets of
data: the variations of initial rates with donor and acceptor
concentrations and of transfer/hydrolysis ratios (T/H) with the
acceptor concentration.
RESULTS
Mutagenesis, production and purfflcation
The three modified plasmids, pDML42 (Thr301Ile), pDML43
(Thr301Ser) and pDML39 (Thr299Val) were purified. That no
additional, unwanted mutations had been introduced was verified
as follows: firstly, the modified gene fragment was sequenced in
M13 immediately after the site-directed-mutagenesis procedure
and, secondly, after reinsertion in the Streptomyces plasmid, the
same fragment was again subcloned in Ml3 and the presence of
the mutation confirmed by sequencing.
Maximum productions were obtained after 120 and 72 h of
growth in the YEMET medium (Thr301Ile and Thr301Ser) and in
the TSB medium (Thr299Val) respectively, as observed for the
wild-type enzyme in both cases. The yields were 100 mg/l for the
Thr301Ile and Thr301Ser mutants, 6 mg/l for the Thr299Val mutant.
The production of the Thr299Val enzyme was thus relatively low
when compared with that of the wild-type enzyme under the
same conditions (usually about 30-40 mg/l).
Purification of the three modified proteins were performed as
described by Wilkin et al. (1993a). The final yields were 80% for
the Thr30lIle and Thr30'Ser and 66% for the Thr29'Val mutants
respectively. The purity of the mutant proteins was evaluated as
higher than 95 % by SDS/PAGE.
Physical properties and stability
Absorption (230-320 nm) and fluorescence emission (excitation
at 280 nm) spectra of the three modified proteins were
superimposable on those of the wild-type enzyme. Moreover, the
mutations did not result in major modifications of the protein
stabilities (Table 2).
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Table 2 Halt-lives of the wild-type and mutant enzymes
The quenching of fluorescence emission of 0.2 ,uM enzyme solutions (Aexcftaion = 280 nm;
Aemiss.on = 320 nm) was continuously recorded.
Half-lives (min)








































Thus, the structures of the Thr301Ile, Thr301Ser and Thr299Val




Table 3 shows the hydrolytic profiles of the three modified
enzymes. In all cases, fluorescence-quenching experiments al-
lowed us to reveal the acyl-enzyme at [S] > Km, with substrates
S2a, S2d and S2val showing that the hydrolysis ofthose substrates
remained k3-limiting (k3 < k2), as found with the wild-type
enzyme. Moreover, this assumption was corroborated by the
similar kcat values for substrates Sle, S2a and S2c (Table 1),
which form the same acyl-enzyme.
Transpeptidase activity
Figure 1 compares the effects of increasing D-alanine
concentrations on the kcat and Km values of the wild-type,
Thr30Ile and Thr30tSer protein. As observed with the wild-type
enzyme, the kcat curve fitted the empirical equation:
kcat a+b[A]ca.I+c[A]
The D-alanine concentrations [A] corresponding to half-satu-
ration ([A]50) were about 100 and 590 mM ([A]50 = I/c) for the
Thr301Ile and Thr301Ser enzymes respectively, while the wild-type
value was 50 mM. Since Km increased according to a similar
equation, the kcat/Km was not significantly modified, as found
for the wild-type enzyme. Thus the behaviour of the mutants
seemed to be similar to that of the wild-type enzyme if one
excepts the increase of the [A]50 values. At low acceptor
concentrations, kcat increased linearly with the acceptor
concentrations, and the quality of an acceptor could be
characterized by the 6kcat/6[A] ratio or by the relative ac-
celeration, 6kcat /(8[A] - kcat.)
Thr30tIle: kCt./8[A] = 640 +100 (M-1s-)
tYCcat./(8[A] kCat.) = 460 + 80 (M-1)
Thr301Ser: 8kcat/8[A] = 860 ± 90 (M-1 s-1)
6kCat./(8[A] kCat.) = 540 + 60 (M-1)
Wild-type: 8kcat/8[A] = 3340 ± 350 (M-1 s-1)
4kcat./(6[A] kcat.) = 670+ 70 (M-1) (Jamin et al.1991)
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Figure 1 Influence of the D-alanine concentration on the k. and K, values
for the hydrolysis of 82a by the wild-type (O), Thruille (OI) and ThrNl1Ser(f db)enzymes Figure 2 Variation of the T/H ratios with increasing concentrations ofD-alanine (37 ° C)
(a) kt. values; (b) Km values. Initial-rate measurements or the complete-time-course method(De Meester et al., 1987) were used at 37 OC in 10 mM sodium buffer, pH 7.0. Values for the
wild-type enzyme are from Jamin et al. (1991). Results are means + S.D. (n = 7 or more). The
kcat/Km values (not shown) were not significantly influenced.
With the Thr299Val enzyme, the presence of the acceptor failed to
increase the rate of donor hydrolysis (Table 4), indicating that
the transpeptidation was not faster than the hydrolysis in the
absence of acceptor.
Figures 2(a) and 2(b) show the transpeptidation/hydrolysis
ratios (T/H ratios) measured with the three mutants under
steady-state conditions (less than 10% utilization of the donor
substrate). As observed with the wild-type enzyme, these data
indicated a clear saturation effect. The T/H ratios were not
strongly affected for the Thr30lIle and Thr30'Ser enzymes, in
The donor substrate was 250 uM S2a in 10 mM sodium phosphate, pH 7.0. (a) wild-type (0),
Thr301lle (A) and Thr301Ser (a) enzymes; (b) wild-type (0) and Thr299Val (K) enzymes.
The continuous curve are theoretical and were obtained by introducing the parameters of Table
8 into eqn. (6) of Jamin et al. (1993).
contrast with the Thr299Val mutant, for which the T/H ratios
remained lower than 5 % of those observed with the wild-type.
Interaction with /J-lactams
Table 5 gives an overview of the acylation (k+2/K') and
deacylation (k+3) parameters, and Table 6 details the individual
values of k+2 and K' for carbenicillin and the three mutant
enzymes.
For the Thr299Val enzyme, the values of k+2/K' decreased
Table 4 Influence of acceptor concentrations on the kt, K. and ktlk, values for the wild-type and Thr2"Val enzymes with S2a as donor substrate
Methods used to calculate the steady-state parameters (M) were: A, complete-time-course method (De Meester et al., 1987); B, initial-rate measurements. S.D. values did not exceed 15%.
ThrzwVal Wild-type





A 5.0 0.05 100
B 28.1 0.28 100
A 63.8 0.65 97.4
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Table 5 k+2IK' and k13 values for several antibiotUcs with the wild-type and mutant enzymes
Abbreviation: Benzylp-Me, benzylpenicillin methylester. Notes: *value from Varetto et al. (1991). The numbers refer to the various procedures described in Wilkin et al. (1993a): lafluorescence
quenching; ibreporter substrate method; 3re-activation of the isolated acylenzyme; "csampling procedure (Varetto et al., 1987): apparent first-order rate constants of 2.7 x 10-4 (s-1) and
9.4 x 10-5 (s-1) were obtained for 2.4 mM cephalosporin C and 1.6 mM cefuroxime respectively; these values would translate into 0.1 and 0.05 M-1 *s-1 k+2/K' values, but at these high
antibiotics concentrations the cephalosporin concentrations might no longer be much smaller than K'. S.D. values did not exceed 15%; ND, not determined.
Thr2zVal Thr30 Ile Thr301Ser Wild-type
Antibiotic (M2-1 - s-') k+31 (M2-1 s-') k,31 (M2-1 . S-1) k+31 (M2-1 - s-1) (s 31)
Benzylpenicillin 1a6OO 35.4 x 10-4 1a46o 31 .5 x 10-4 1a4OOO 33.5 x 10-4 1180ooo 31 .4 x 10-4
Carbenicillin 1a26 35.5 x 10-4 la1800 31 .8 x 10-4 18360 33.5 x 10-4 la830 31 .4 x 10-4
Ampicillin la2 32.7 x 10-4 la35 32.0 x 1° 0-4 lalll 33.5 x 1° 0-4 laiii 31 .4 x 10-4
Benzylp-Me la1 ND ND ND ND ND la24 31.0 x 10-5*
Nitrocefin lb30 32.5 x 10-3 lal140 36.0 x 10-4 la680 33.6 x 10-4 1a4100 33.0 x 10-4
Cephalosporin C lc < 1 39Q° x 10-6 1a3OO 31 .5 x 10-6 1a850 ND 1al500 31.0 x 10-6
Cefuroxime lc < 1 32.2 x 10-5 1al30 31.2 x 10-6 la43Q ND a350 3 < 4 x 10-6
Table 6 Individual k+2 and K' values for carbenicillin and the wild-type and
mutant enzymes
The fluorescence quenching results from method 1 a in Wilkin et al. (1 993a) were analysed with
the help of ENZFITTER program.
Carbenicillin














30-50-fold with penicillins and more than three orders of
magnitude for cephalosporins. For carbenicillin, the decrease
could be attributed to an increased K' value.
The Thr301 mutants were much less affected and the properties
of the Thr301Ser protein were not very different from those of the
wild-type. Surprisingly, the individual values of kI2 and K' for
carbenicillin were increased by similar factors, which explained
the small variations of the resulting k+2/K' values.
The k+3 values for the Thr301 mutant enzymes did not seem to
be affected. Conversely, for the Thr299Val mutant, there was a 10-
fold increase in nitrocefin, cefuroxime and cephalosporin C.
At pH 7.0, the Thr299Val enzyme also exhibited a significant
increase of the penicilloic acid/phenylacetylglycine ratio during
the re-activation step: 0.6+0.1 versus < 0.1 for the wild-type.
DISCUSSION
The physical properties of the three modified proteins, including
their thermal stabilities, were not significantly different from
those of the WT enzyme, which indicated the absence of
important structural alterations. Accordingly, the mutants
retained, to various degrees, some of the catalytic and/or
penicillin binding properties of the original enzyme.
ThrW'l
As explained in the Introduction, and on the basis of the results
obtained with the TEM ,J-lactamase, one might have expected
selective alterations of the sensitivity of the DD-peptidase to
penicillins and cephalosporins after replacement of the Thr30'
residue by Ile (elimination of a possible H-bonding function) or
by Ser (a smaller residue conserving the H-bonding function). In
contrast with these expectations, the modifications did not result
in dramatic changes of the protein properties. The Thr301Ser
mutation barely affected the rates of substrate utilization and of
acylation by pencillins, the largest factor (4.5) being observed
with benzylpenicillin. The Thr301Ile mutant was somewhat more
affected, up to 40-fold, again with benzylpenicillin. Unexpectedly,
the decrease of kcat /Km value for the tripeptide substrate was less
important (6-fold), so that this protein could be considered as a
DD-peptidase exhibiting increased benzylpencillin resistance. This
Table 7 Kinetc parameters for the concomitant hydrolysis and aminolysis (D-alanine) of substrate S2a catalysed by the R61 DD-pepUdase at 37 ° C
The k2/K' and k+3 values were those directly measured in the absence of acceptor. The other parameters were obtained by fitting initial rates (except for the Thr299Val enzyme) and T/H ratios
on eqn. (1) of the Materials and methods section and eqn. (6) of Jamin et al. (1993). S.D. values are the averages of the S.D. values obtained after each fitting experiment.
Constants Thr30lle Thr301Ser Thr299Val Wild-type
k2/K' (mM1- s-)
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Table 8 Comparison of the kinetic parameters of DD-transpeptdase mutants
The T/H values were obtained with 250 ,uM S2a and 10 mM o-alanine as donor and acceptor substrates respectively. Values in square brackets were computed from kcat increases; the real T/Hvalues might thus be somewhat lower. All the kinetic parameters are taken from Hadonou et al. (1992) and Wilkin et al. (1 993a,b). Abbreviations used: Pen G, penicillin G; Ceph C, cephalosporin
C.
Substrates Inhibitors
Peptide Thiolester Pen G Ceph C

















































































conclusion could, however, not be extended to the other tested ,-
lactams, for which the rates of acylation only decreased 3-8-fold.
If one excepts the benzylpenicillin-Thr301Ile interaction, no
modification of the penicillin-versus-cephalosporins pattern
could be detected.
Previous experiments have shown the transpeptidation
properties to be highly sensitive to most structural modifications
(Hadonou et al., 1992; Wilkin et al., 1993a,b).
The detailed analysis of the data (Table 7), however, indicated
some interesting features with both mutants, the a values were
somewhat increased and thus contributed to decreasing the T/H
ratios, a trend which was reinforced by the lower k+5 value of theThr301Ile mutant. Interestingly, the k+7 value for the Thr301Ser
mutant was slightly increased, which explained the higher kcat
values observed with this protein at large acceptor concentra-
tions, a somewhat paradoxical result, similar to that obtained
with the Asn"'6Ser mutant with which an increased relative
efficiency of the 'vertical' hydrolysis pathway (Model 2) was also
observed (Wilkin et al., 1993b).
Finally, the significant increase (30-fold) of the K' value for
carbenicillin was rather surprising and contrasted with the
situation with the peptide substrate, for which Km (= K', rate-
limiting acylation) increased only 4-fold with Thr301Ile and not at
all for Thr301Ser.
In consequence, it can be concluded that the side chain of
residue 301 only plays a minor role in the interactions with the
peptide substrates and ,-lactam inactivators of the enzyme. As
proposed by Kelly et al. (1989), the functions of this residue
mainly involve its backbone amide NH and CO groups re-
spectively in contributing to the oxyanion hole and in forming a
hydrogen bond with the amide NH of the side chain on C-6 of
penicillins or C-7 ofcephalosporins, and these interactions should
not be significantly altered by the mutations performed here.
Thr2"
In contrast with the results discussed above, the Thr299Val
mutation resulted in marked modifications of the enzymic
properties. Modelling of the Henri-Michaelis complexes formed
upon binding penicillins in the active sites of various-class A fi-
lactamases indicated that the hydroxy group ofthe corresponding
Thr235 or S-er235 residue could hydrogen-bond to the substrate
carboxylate, contributing to its proper positioning in the enzyme
cavity (Moews et al., 1990; Lamotte-Brasseur et al., 1991;
Strynadka et al., 1992). The validity of this hypothesis was tested
by replacing Thr299 by a Val residue.
This resulted in a dramatic decrease (700-fold) of the kcat./Kmvalue for the peptide substrate and in a strong impairment of the
esterase activity. The thiolesterase activity was, conversely, much
less affected, but a similar situation appears to prevail with
many other mutants of the R61 DD-peptidase, including,
interestingly, those in which the neighbouring His298 residue has
been replaced by Gln or Lys.
Even when the Thr299 and His298 mutants retained an important
fraction of their hydrolytic capacities (against the thiolester
S2a), the transpeptidase activities were nearly totally abolished.
Residue 298 had been hypothesized to play a pivotal role in the
transpeptidation reaction (Hadonou et al., 1992), but this activity
was even more affected by the Thr299Val mutation. As shown in
Table 7, the loss of transpeptidase activity could be attributed to
a dramatic (100-fold) decrease of the k+ value with the Thr299Val
mutant.
Several residues have now been identified as playing a
significant role in the transpeptidation reaction (Table 8) and,
among these, Tyr'59 and Thr299 appear to be the most essential.
Strikingly, the impairment of the transpeptidation efficiency
appears to closely parallel that of the hydrolysis of the peptide
substrate, and these two phenomena relate to different parts of
the reaction pathway. Indeed, in the hydrolysis of the peptide,
acylation is rate-limiting, and what occurs after formation of the
acyl-enzyme has little influence on the rate of the reaction, while
the transpeptidation pathway only contains intermediates derived
from the acyl-enzyme. Thus Thr299 and Tyr'59 are deeply involved
in both stages of the reactions when the natural substrates are
transformed.
Modification of the Thr299 side chain significantly decreased
the rates of acylation by penicillins (30-50-fold), and,
interestingly, the reaction with cephalosporins became ex-
ceedingly slow. Only nitrocefin retained a non-negligible in-
activating potency, but the behaviour of this compound has
often been found to be rather different from that of more
classical cephems. The modified enzyme thus became practically
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resistant to cefuroxime and cephalosporin C, a situation remi-
niscent of that observed with the peptide substrate. It was
somewhat surprising to note that the decreased k+2/K' values for
carbenicillin and the tripeptide were due to an increased K' and
decreased k+2 (= kcat.) respectively, a result which might indicatethat it is somewhat artificial to try to individualize the two
constants which determine the rate of acylation, but which could
also reflect distinct behaviours of the substrate and inactivators
in the enzyme catalytic site.
The behaviour of the benzylpenicillin methyl ester was more
surprising. Indeed, when compared with benzylpenicillin, its
efficiency was decreased by similar factors with the wild-type
(800-fold) and the mutant (600-fold) enzymes. The disappearance
of the Thr299 hydroxy group thus similarly decreases the
efficiencies of both benzylpenicillin and its ester.
These results and others presented here will be further discussed
in the companion paper (Dubus et al., 1994), which analyses the
consequences of mutations of the corresponding residues in a
class A and a class Cfl-lactamase.
Conclusion
The relatively importance of the two threonine residues of the
,/3-strand is very different in the R61 DD-peptidase. The side
chain of residue Thr301 plays a minor role and its modification
only results in subtle alterations of the specificity pattern of the
enzyme. By contrast, that of Thr299 is a major participant in
several important events in the catalytic cycle.
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